International Flavors & Fragrances Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +50

IFF Q1 Earnings Beat Estimates on Volume Growth & Productivity Gains

AI-generated analysis

πŸ“ˆ IFF reported adjusted earnings of $1.25 per share in Q1 2026, up 4.2% year-over-year and beating the Zacks Consensus Estimate of $1.08 by 15.7%.

πŸ’° Including one-time items, earnings rose from a prior-year loss of $3.98 to 66 cents per share for the quarter.

πŸ“‰ Net sales totaled $2.741 billion, down 3.6% year-over-year but remaining 3.4% above the analyst consensus mark.

πŸ’§ On a comparable currency-neutral basis, sales grew 3% driven by volume gains across all four business segments.

πŸ“‰ Cost of goods sold decreased 5% to $1.7 billion, while gross profit dipped 1.6% to approximately $1 billion.

πŸ“Š Gross margin expanded to 37.1%, compared with 36.4% in the same period last year.

🧬 Research and development expenses fell 7.4% to $427 million, while selling and administrative expenses rose slightly to $166 million.

πŸ’Έ Adjusted operating EBITDA reached $568 million, representing an 11.6% increase from the prior-year quarter.

πŸ“ˆ Currency-neutral adjusted operating EBITDA improved 8% year-over-year on the back of volume growth and productivity gains.

πŸ§‚ The Taste segment saw net sales rise 5.6% to $656 million, though adjusted operating EBITDA dropped 29% to $153 million.

🍫 Food Ingredients sales climbed 7.7% to $839 million, with currency-neutral growth of 3% driven by volume increases.

πŸ’Š Health & Bioscience generated $595 million in sales, up 10% year-over-year, led by growth in Animal Nutrition and Food Biosciences.

🌸 The Scent segment reported $651 million in sales, a 6% year-over-year increase with mixed performance across sub-sectors.

πŸ’΅ Cash flow from operations strengthened significantly to $257 million, compared to just $1.27 million in the prior-year quarter.

🏦 IFF ended the quarter with $562 million in cash and equivalents, while maintaining long-term debt at $4.74 billion for a net debt-to-EBITDA ratio of 2.5x.

βœ… Management reaffirmed full-year 2026 guidance despite an unsettled operating environment, expecting sales between $10.5 billion and $10.8 billion.

πŸ”„ The company updated its full-year view following the March 2, 2026 divestiture of its Soy Crush, Concentrates and Lecithin business.

πŸš€ IFF is currently progressing a disciplined sale process for its Food Ingredients business to maximize shareholder value.

⚠️ IFF shares have lost 6% over the past year, lagging the industry's growth rate of 4.6%.

πŸ“‰ Linde plc and PPG Industries also reported strong Q1 earnings results with revenue beats or meeting estimates.

🎨 Sherwin-Williams reported first-quarter earnings of $2.15 per share, up 7.5% year-over-year from the prior period.

Bullish Signals
  • IFF reported adjusted earnings of $1.25 per share, which beat the Zacks Consensus Estimate of $1.08 by 15.7%.
  • On a comparable currency-neutral basis, quarterly net sales increased 3%, supported by volume gains across all four segments.
  • The company achieved better operating execution with cost of goods sold down 5% year over year to $1.7 billion.
  • Gross margin expanded to 37.1% compared with 36.4% in the prior-year quarter, demonstrating improved pricing or mix.
  • Research and development expenses decreased 7.4% year over year to $427 million, indicating cost efficiency.
  • Adjusted operating EBITDA rose 11.6% to $568 million from the prior year's $509 million.
  • Cash generation improved meaningfully with International Flavors generating $257 million in cash from operating activities compared to just $1.27 million in the prior-year quarter.
  • The Food Ingredients segment delivered strong sales growth of 7.7% year over year, driven by volume increases in nearly all businesses.
  • IFF reaffirmed its full-year 2026 guidance, projecting sales between $10.5 billion and $10.8 billion despite an unsettled operating environment.
  • Management maintains a conservative outlook with expected comparable currency neutral adjusted operating EBITDA growth of 3-8% for the year.
  • IFF is progressing a disciplined sale process for its Food Ingredients business to maximize shareholder value.
Risk Factors
  • Quarterly net sales declined 3.6% year over year to $2.741 billion, signaling weakness in top-line growth despite beat on earnings.
  • The Taste segment's adjusted operating EBITDA fell 29% year over year, indicating significant profitability contraction in a key revenue stream.
  • Scent segment growth was muted with only 1% comparable sales increase, as expansion in Consumer/Fine Fragrances was offset by declines in Fragrance Ingredients.
  • IFF generated $257 million in cash from operating activities compared to just $1.27 million in the prior-year quarter, highlighting substantial volatility in cash flow generation.
  • Cash and cash equivalents dropped from $590 million at the end of 2025 to $562 million at the end of first-quarter 2026, reflecting a burn of capital reserves.
  • The company's shares lost 6% over the past year while the broader industry grew by 4.6%, underperforming its sector peers despite an earnings beat.
  • IFF reaffirmed full-year guidance in what management described as an 'unsettled operating environment,' adding uncertainty to future outlooks.
  • Long-term debt remained elevated at $4.74 billion, with net debt to credit adjusted EBITDA at 2.5x, leaving limited financial flexibility against rising interest rate risks.
Full Analysis
IFF reported adjusted earnings of $1.25 per share for the first quarter of 2026, representing a 4.2% year-over-year increase that significantly beat the Zacks Consensus Estimate of $1.08 by 15.7%. While quarterly net sales declined 3.6% year over year to $2.741 billion, the performance on a comparable currency-neutral basis showed a 3% increase driven by volume growth across all four segments. Cost management was a key driver of this operational strength, with the cost of goods sold down 5% year over year and adjusted operating EBITDA rising 11.6% to $568 million, improving the margin to 20.7% from 17.9%. All four business segments contributed to volume growth, though their specific financial contributions varied. The Taste segment saw sales rise 5.6% year over year, while Food Ingredients grew 7.7% and Health & Bioscience increased by approximately 10.4%. Scent sales rose 6% but faced a slight decline in Fragrance Ingredients which was offset by growth in Consumer and Fine Fragrances. Cash generation improved significantly with $257 million generated from operating activities compared to $1.27 million in the prior year, resulting in free cash flow of $92 million after capital expenditures of $165 million. Despite a decline in cash and cash equivalents to $562 million at quarter-end and no change in long-term debt at $4.74 billion, IFF maintained its net debt to credit adjusted EBITDA multiple at 2.5x. Management reaffirmed full-year 2026 guidance expecting sales between $10.5 billion and $10.8 billion, with comparable currency neutral sales growth projected between 1% and 4%. The company also provided an update following the divestiture of its Soy Crush, Concentrates, and Lecithin business which closed on March 2, 2026, while continuing to pursue a disciplined sale process for the broader Food Ingredients business. In terms of stock performance, IFF shares have lost 6% over the past year while the industry grew by 4.6%, leading Zacks Investment Research to maintain the ticker with a Rank #3 (Hold). The article notes that this earnings report was part of a broader commentary on related companies like Linde plc and PPG Industries, but IFF remains the primary subject due to the depth of its financial reporting and strategic updates regarding portfolio actions.